Patents Assigned to Seikgaka Corporation
  • Patent number: 6184023
    Abstract: A crystallizable, purified chondroitinase ABC having a molecular weight of about 100,000 dalton by the measurement of the SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and the measurement by the gel permeation chromatography method, having alanine as the N-terminal amino acid and proline as the C-terminal amino acid. A process for the purification of the crystallizable purified chondroitinase ABC comprising removing nucleic acid from an surfactant solution extract obtained from cells of chondroitinase ABC-producing microorganisms and chromatographically treating by concentration gradient elution using a weak cation exchange resin or a strong cation exchange resin. A composition comprising a chondroitinase and serum albumin, gelatin, or a nonionic surfactant.
    Type: Grant
    Filed: July 7, 1997
    Date of Patent: February 6, 2001
    Assignee: Seikgaka Corporation
    Inventors: Nobukazu Hashimoto, Hideo Mochizuki, Akio Hamai